National Institute of Allergy & Infectious Diseases: Clinical Trial of MRNA Universal Influenza Vaccine Candidate Begins
May 16, 2023
May 16, 2023
WASHINGTON, May 16 (TNSres) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolin . . .
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolin . . .